Q3 2024 13F Holders as of 9/30/2024
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
56.2M
-
Number of holders
-
441
-
Total 13F shares, excl. options
-
55.3M
-
Shares change
-
-307K
-
Total reported value, excl. options
-
$8.23B
-
Value change
-
+$2.81M
-
Put/Call ratio
-
0.71
-
Number of buys
-
222
-
Number of sells
-
-232
-
Price
-
$148.82
Significant Holders of REPLIGEN CORP - COMMON STOCK (RGEN) as of Q3 2024
541 filings reported holding RGEN - REPLIGEN CORP - COMMON STOCK as of Q3 2024.
REPLIGEN CORP - COMMON STOCK (RGEN) has 441 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 55.3M shares
of 56.2M outstanding shares and own 98.39% of the company stock.
Largest 10 shareholders include BlackRock, Inc. (7.11M shares), PRICE T ROWE ASSOCIATES INC /MD/ (6.39M shares), VANGUARD GROUP INC (5.04M shares), STATE STREET CORP (1.62M shares), Champlain Investment Partners, LLC (1.42M shares), SANDS CAPITAL MANAGEMENT, LLC (1.42M shares), Bank of New York Mellon Corp (1.36M shares), MACQUARIE GROUP LTD (1.2M shares), BROWN CAPITAL MANAGEMENT LLC (1.12M shares), and Impax Asset Management Group plc (1.06M shares).
This table shows the top 441 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.